propidium has been researched along with cx 4945 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arús, C; Candiota, AP; Martínez-Escardó, L; Villamañan, L; Yuste, VJ | 1 |
1 other study(ies) available for propidium and cx 4945
Article | Year |
---|---|
Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Calreticulin; Casein Kinase II; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Glioblastoma; Humans; Inflammation; Microscopy, Fluorescence; Naphthyridines; Phenazines; Propidium; Signal Transduction; Temozolomide; Treatment Outcome | 2021 |